{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:27:05Z","timestamp":1793896025758,"version":"4.8.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005329","name":"Natural Science Foundation of Guizhou Province","doi-asserted-by":"publisher","award":["KXJZ[2025]014"],"award-info":[{"award-number":["KXJZ[2025]014"]}],"id":[{"id":"10.13039\/501100005329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005329","name":"Natural Science Foundation of Guizhou Province","doi-asserted-by":"publisher","award":["QKHZDZX[2024]015"],"award-info":[{"award-number":["QKHZDZX[2024]015"]}],"id":[{"id":"10.13039\/501100005329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110032","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:03:20Z","timestamp":1779984200000},"page":"110032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Structure-optimized 4-trifluoromethylquinoline derivatives: Dual enhancement of SGK1 inhibition and anti-prostate cancer efficacy"],"prefix":"10.1016","volume":"180","author":[{"given":"Yafang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangcan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.bioorg.2026.110032_bb0005","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2025.0228","article-title":"Prostate cancer: A review","volume":"333","author":"Raychaudhuri","year":"2025","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110032_bb0010","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1021\/acs.jmedchem.3c00996","article-title":"Discovery of novel inhibitors of BRD4 for treating prostate cancer: A comprehensive case study for considering water networks in virtual screening and drug design","volume":"67","author":"Zhong","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110032_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2025.101359","article-title":"Targeting and engineering biomarkers for prostate cancer therapy","volume":"103","author":"Senapati","year":"2025","journal-title":"Mol. Aspects Med."},{"issue":"21","key":"10.1016\/j.bioorg.2026.110032_bb0020","doi-asserted-by":"crossref","first-page":"19395","DOI":"10.1021\/acs.jmedchem.4c01752","article-title":"Identification of oral bioavailable coumarin derivatives as potential AR antagonists targeting prostate cancer","volume":"67","author":"Liao","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110032_bb0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/0008-5472.CAN-24-0133","article-title":"Stimulating soluble guanylyl cyclase with the clinical agonist riociguat restrains the development and progression of castration-resistant prostate cancer","volume":"85","author":"Zhang","year":"2025","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110032_bb0030","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","article-title":"Prostate cancer, version 4.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Schaeffer","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110032_bb0035","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1021\/acs.jmedchem.3c01668","article-title":"Design and synthesis of dual-target inhibitors targeting androgen receptors and glucocorticoid receptors to overcome antiandrogen resistance in castration-resistant prostate cancer","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2026.110032_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202309261","article-title":"Discovery of novel anti-resistance AR antagonists guided by funnel metadynamics simulation","volume":"11","author":"Chen","year":"2024","journal-title":"Adv. Sci."},{"issue":"18","key":"10.1016\/j.bioorg.2026.110032_bb0045","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1021\/acs.jmedchem.2c01164","article-title":"Design, synthesis, and biological evaluation of androgen receptor degrading and antagonizing bifunctional steroidal analogs for the treatment of advanced prostate cancer","volume":"65","author":"Wang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110032_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108743","article-title":"Nutraceuticals target androgen receptor-splice variants (AR-SV) to manage castration resistant prostate cancer (CRPC)","volume":"264","author":"Tyagi","year":"2024","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110032_bb0055","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.ccell.2024.10.015","article-title":"Elucidating acquired PARP inhibitor resistance in advanced prostate cancer","volume":"42","author":"Seed","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioorg.2026.110032_bb0060","doi-asserted-by":"crossref","unstructured":"A.R. Leslie, S. Ning, C.M. Armstrong, L.S. D'Abronzo, M. Sharifi, Z.A. Schaaf, W. Lou, C.F. Liu, C.P. Evans, A.P. Lombard, A.C. Gao, IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancer, iScience 27(2) (2024) 108984, Doi: https:\/\/doi.org\/10.1016\/j.isci.2024.108984.","DOI":"10.1016\/j.isci.2024.108984"},{"issue":"28","key":"10.1016\/j.bioorg.2026.110032_bb0065","doi-asserted-by":"crossref","first-page":"33309","DOI":"10.1021\/acsami.3c04167","article-title":"Two-in-one polymeric NO-donor prodrugs mediate precision and synergistic prostate cancer treatment","volume":"15","author":"Zhao","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"19","key":"10.1016\/j.bioorg.2026.110032_bb0070","doi-asserted-by":"crossref","first-page":"17290","DOI":"10.1021\/acs.jmedchem.4c01100","article-title":"Discovery of a Highly potent PROTAC degrader of p300\/CBP proteins for the treatment of enzalutamide-resistant prostate cancer","volume":"67","author":"Ma","year":"2024","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110032_bb0075","first-page":"2031","article-title":"Characterization of sgk, a novel member of the serine\/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum","volume":"13","author":"Webster","year":"1993","journal-title":"Mol. Cell. Biol."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110032_bb0080","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/s41401-018-0087-6","article-title":"Identification, structure modification, and characterization of potential small-molecule SGK3 inhibitors with novel scaffolds","volume":"39","author":"Gong","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110032_bb0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrm2822","article-title":"The nuts and bolts of AGC protein kinases","volume":"11","author":"Pearce","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.110032_bb0090","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920940946","article-title":"The prospect of serum and glucocorticoid-inducible kinase 1 (SGK1) in cancer therapy: a rising star","volume":"12","author":"Zhu","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110032_bb0095","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1021\/acschembio.9b00505","article-title":"Design and characterization of SGK3-PROTAC1, an isoform specific SGK3 kinase PROTAC degrader","volume":"14","author":"Tovell","year":"2019","journal-title":"ACS Chem. Biol."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110032_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108821","article-title":"SGK1 signaling promotes glucose metabolism and survival in extracellular matrix detached cells","volume":"34","author":"Mason","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bioorg.2026.110032_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.608722","article-title":"SGK1 in human cancer: Emerging roles and mechanisms","volume":"10","author":"Sang","year":"2021","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110032_bb0110","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.apsb.2018.07.001","article-title":"Serum and glucocorticoid inducible protein kinases (SGKs): A potential target for cancer intervention","volume":"8","author":"Basnet","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110032_bb0115","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/bjc.2017.293","article-title":"SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway","volume":"117","author":"Liu","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"18","key":"10.1016\/j.bioorg.2026.110032_bb0120","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1158\/0008-5472.CAN-08-1047","article-title":"Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic","volume":"68","author":"Sherk","year":"2008","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110032_bb0125","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-018-0743-1","article-title":"SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT","volume":"37","author":"Liu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110032_bb0130","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2013.11.012","article-title":"Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade","volume":"155","author":"Arora","year":"2013","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110032_bb0135","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12672-014-0173-2","article-title":"Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer","volume":"5","author":"Isikbay","year":"2014","journal-title":"Horm. Cancer"},{"key":"10.1016\/j.bioorg.2026.110032_bb0140","article-title":"The circRAB3IP mediated by eIF4A3 and LEF1 contributes to enzalutamide resistance in prostate cancer by targeting miR-133a-3p\/miR-133b\/SGK1 pathway","volume":"11","author":"Chen","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110032_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2022.104462","article-title":"Bioanalytical method validation, biopharmaceutical and pharmacokinetic evaluation of GSK-650394, a serum- and glucocorticoid-regulated kinase 1 inhibitor","volume":"16","author":"Le","year":"2023","journal-title":"Arabian Journal of Chemistry"},{"key":"10.1016\/j.bioorg.2026.110032_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109546","article-title":"Is it feasible for CDKs inhibitors to herald a new era in tackling the low sensitivity and drug resistance associated with PARP inhibitors?","volume":"172","author":"Wang","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110032_bb0155","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s11030-024-10951-4","article-title":"Discovery of novel 4-trifluoromethyl-2-anilinoquinoline derivatives as potential anti-cancer agents targeting SGK1","volume":"29","author":"Xu","year":"2025","journal-title":"Mol. Divers."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110032_bb0160","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.bmc.2011.11.016","article-title":"Substrate specificity of acetoxy derivatives of coumarins and quinolones towards calreticulin mediated transacetylation: investigations on antiplatelet function","volume":"20","author":"Kathuria","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110032_bb0165","doi-asserted-by":"crossref","unstructured":"Z.Z. Tian, Z.P. Xu, S.X. Cui, D.M. Li, Design, synthesis and insecticidal activities of dihydropyridine-fused neonicotinoids compounds with trifluoromethyl group, Res. Chem. Intermed. 41(10) (2015) 7437\u20137447, Doi: 10.18632\/aging.100934.","DOI":"10.1007\/s11164-014-1835-y"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110032_bb0170","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1021\/acs.jmedchem.8b01755","article-title":"Discovery of novel quinoline-chalcone derivatives as potent antitumor agents with microtubule polymerization inhibitory activity","volume":"62","author":"Li","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110032_bb0175","doi-asserted-by":"crossref","unstructured":"G. Pistritto, D. Trisciuoglio, C. Ceci, A. Garufi, G. D\u2019Orazi, Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies, Aging 8(4) (2016) 603\u2013619, Doi: 10.18632\/aging.100934.","DOI":"10.18632\/aging.100934"},{"key":"10.1016\/j.bioorg.2026.110032_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129239","article-title":"Synthesis, in vitro cytotoxicity evaluation and mechanism of 5\u2032 monosubstituted chalcone derivatives as antitumor agents","volume":"85","author":"Xu","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110032_bb0185","article-title":"New pyrazolyl-thiazolidinone\/thiazole derivatives as celecoxib\/dasatinib analogues with selective COX-2, HER-2 and EGFR inhibitory effects: design, synthesis, anti-inflammatory\/anti-proliferative activities, apoptosis, molecular modelling and ADME studies","volume":"38","author":"Fadaly","year":"2023","journal-title":"Enzyme Inhib. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110032_bb0190","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1158\/0008-5472.CAN-19-0458","article-title":"Defining the hallmarks of metastasis","volume":"79","author":"Welch","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110032_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113653","article-title":"Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma","volume":"223","author":"Rango","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110032_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117336","article-title":"Hit to lead optimization of the 4-trifluoromethylquinoline derivatives as novel SGK1 inhibitors with potent anti-prostate cancer activity","volume":"287","author":"Li","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110032_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139074","article-title":"Design, synthesis and pharmacological evaluation of novel thiazole derivatives as c-Met kinase inhibitors and anticancer agents","author":"Gediya","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110032_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109792","article-title":"Design, synthesis, and in silico study of VEGFR-2 and HDAC dual acting quinazoline based molecules for anticancer evaluation","volume":"175","author":"Abdallah","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110032_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109389","article-title":"Exploring quinoline-linked chalcones as broad-spectrum antimicrobial agents: Synthesis, antibacterial, antifungal, molecular docking, pharmacokinetics, and DFT investigation","volume":"169","author":"Tidke","year":"2026","journal-title":"Bioorg. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826005687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826005687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:00:15Z","timestamp":1793894415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826005687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":43,"alternative-id":["S0045206826005687"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110032","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-optimized 4-trifluoromethylquinoline derivatives: Dual enhancement of SGK1 inhibition and anti-prostate cancer efficacy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110032"}}